These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 24256948)
1. Antibody VH and VL recombination using phage and ribosome display technologies reveals distinct structural routes to affinity improvements with VH-VL interface residues providing important structural diversity. Groves MA; Amanuel L; Campbell JI; Rees DG; Sridharan S; Finch DK; Lowe DC; Vaughan TJ MAbs; 2014; 6(1):236-45. PubMed ID: 24256948 [TBL] [Abstract][Full Text] [Related]
2. Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1. Douthwaite JA; Sridharan S; Huntington C; Hammersley J; Marwood R; Hakulinen JK; Ek M; Sjögren T; Rider D; Privezentzev C; Seaman JC; Cariuk P; Knights V; Young J; Wilkinson T; Sleeman M; Finch DK; Lowe DC; Vaughan TJ MAbs; 2015; 7(1):152-66. PubMed ID: 25484051 [TBL] [Abstract][Full Text] [Related]
3. Engineering a high-affinity anti-IL-15 antibody: crystal structure reveals an α-helix in VH CDR3 as key component of paratope. Lowe DC; Gerhardt S; Ward A; Hargreaves D; Anderson M; Ferraro F; Pauptit RA; Pattison DV; Buchanan C; Popovic B; Finch DK; Wilkinson T; Sleeman M; Vaughan TJ; Mallinder PR J Mol Biol; 2011 Feb; 406(1):160-75. PubMed ID: 21167836 [TBL] [Abstract][Full Text] [Related]
4. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains. van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026 [TBL] [Abstract][Full Text] [Related]
5. The specificity properties that distinguish members of a set of homologous anti-digoxin antibodies are controlled by H chain mutations. Near RI; Bruccoleri R; Novotny J; Hudson NW; White A; Mudgett-Hunter M J Immunol; 1991 Jan; 146(2):627-33. PubMed ID: 1898959 [TBL] [Abstract][Full Text] [Related]
6. Design and Generation of Humanized Single-chain Fv Derived from Mouse Hybridoma for Potential Targeting Application. Khantasup K; Chantima W; Sangma C; Poomputsa K; Dharakul T Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):404-17. PubMed ID: 26683180 [TBL] [Abstract][Full Text] [Related]
7. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin. Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142 [TBL] [Abstract][Full Text] [Related]
8. Structural diversity in a human antibody germline library. Teplyakov A; Obmolova G; Malia TJ; Luo J; Muzammil S; Sweet R; Almagro JC; Gilliland GL MAbs; 2016; 8(6):1045-63. PubMed ID: 27210805 [TBL] [Abstract][Full Text] [Related]
10. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain. Riechmann L J Mol Biol; 1996 Jun; 259(5):957-69. PubMed ID: 8683598 [TBL] [Abstract][Full Text] [Related]
11. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency. Tan PH; Sandmaier BM; Stayton PS Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949 [TBL] [Abstract][Full Text] [Related]
12. Germline-Dependent Antibody Paratope States and Pairing Specific V Fernández-Quintero ML; Kroell KB; Bacher LM; Loeffler JR; Quoika PK; Georges G; Bujotzek A; Kettenberger H; Liedl KR Front Immunol; 2021; 12():675655. PubMed ID: 34447370 [TBL] [Abstract][Full Text] [Related]
13. Fundamental characteristics of the expressed immunoglobulin VH and VL repertoire in different canine breeds in comparison with those of humans and mice. Steiniger SC; Dunkle WE; Bammert GF; Wilson TL; Krishnan A; Dunham SA; Ippolito GC; Bainbridge G Mol Immunol; 2014 May; 59(1):71-8. PubMed ID: 24509215 [TBL] [Abstract][Full Text] [Related]
14. CDR loop interactions can determine heavy and light chain pairing preferences in bispecific antibodies. Fernández-Quintero ML; Kroell KB; Grunewald LJ; Fischer AM; Riccabona JR; Liedl KR MAbs; 2022; 14(1):2024118. PubMed ID: 35090383 [TBL] [Abstract][Full Text] [Related]
15. Construction of an scFv library by enzymatic assembly of V(L) and V(H) genes. Kato M; Hanyu Y J Immunol Methods; 2013 Oct; 396(1-2):15-22. PubMed ID: 23916870 [TBL] [Abstract][Full Text] [Related]
16. A large human domain antibody library combining heavy and light chain CDR3 diversity. Chen W; Zhu Z; Feng Y; Dimitrov DS Mol Immunol; 2010 Jan; 47(4):912-21. PubMed ID: 19883941 [TBL] [Abstract][Full Text] [Related]
17. Improvement of anti-Burkholderia mouse monoclonal antibody from various phage-displayed single-chain antibody libraries. Kim HS; Lo SC; Wear DJ; Stojadinovic A; Weina PJ; Izadjoo MJ J Immunol Methods; 2011 Sep; 372(1-2):146-61. PubMed ID: 21787781 [TBL] [Abstract][Full Text] [Related]
18. Restricted V gene usage and VH/VL pairing of mouse humoral response against the N-terminal immunodominant epitope of the amyloid β peptide. Robert R; Lefranc MP; Ghochikyan A; Agadjanyan MG; Cribbs DH; Van Nostrand WE; Wark KL; Dolezal O Mol Immunol; 2010; 48(1-3):59-72. PubMed ID: 20970857 [TBL] [Abstract][Full Text] [Related]
19. A Combination of Structural and Empirical Analyses Delineates the Key Contacts Mediating Stability and Affinity Increases in an Optimized Biotherapeutic Single-chain Fv (scFv). Tu C; Terraube V; Tam AS; Stochaj W; Fennell BJ; Lin L; Stahl M; LaVallie ER; Somers W; Finlay WJ; Mosyak L; Bard J; Cunningham O J Biol Chem; 2016 Jan; 291(3):1267-76. PubMed ID: 26515064 [TBL] [Abstract][Full Text] [Related]
20. A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties. Tiller T; Schuster I; Deppe D; Siegers K; Strohner R; Herrmann T; Berenguer M; Poujol D; Stehle J; Stark Y; Heßling M; Daubert D; Felderer K; Kaden S; Kölln J; Enzelberger M; Urlinger S MAbs; 2013; 5(3):445-70. PubMed ID: 23571156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]